Kia has officially revealed the name of its upcoming compact SUV and contrary to previous reports, it will be called “Syros”. Although Kia did file a trademark application for the “Syros ...

Your browser does not support the audio element. Kia has announced that its upcoming compact SUV will be called the Syros. Internally codenamed the AY, the Kia Syros ...

Shortly after the teaser sketches of the new SUV were revealed, we have now got to know that it will be now called the Kia Syros. The name ‘Syros’ – which was trademarked by the carmaker in ...

Kia aims to create vehicles that deeply resonate with customers. Advt “Syros will be the first Kia 2.0 SUV offering after Carnival and EV9. It will represent a new chapter in Kia's journey ...

In line with Kia’s new design language, the Syros will sport modern and bold ... While it's not clear, we can spot what appears to be a little spoiler at the top-end of the rear.

Kia is set to expand its footprint in India’s SUV market with the launch of the Kia Syros—the first SUV under the company's new Kia 2.0 strategy. This model is expected to blend modern design ...

Sorry, we can’t find any flight deals flying from Venice Treviso to Syros Island right now.Find a flight How did we find these deals? The deals you see here are the ...

Syros Pharmaceuticals ( (SYRS)) has released its Q3 earnings. Here is a breakdown of the information Syros Pharmaceuticals presented to its investors. Syros Pharmaceuticals, Inc., a ...

SYROS combines the practical attributes of an SUV with Kia’s new-age styling and technology. The design of the SUV aims to stand out in its segment, featuring bold aesthetics, advanced safety features ...

Port Saplaya, known locally as “Little Venice”, just north of Valencia in Spain may be that perfect replacement. Port Saplaya is a purpose-built residential area which houses many holiday ...

Syros Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.16, expectations were $-0.72. Operator: Good morning, and welcome to the Syros Pharmaceuticals Third Quarter 2024 ...